Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Trinity Bio ADR (TRIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,248
  • Shares Outstanding, K 24,040
  • Annual Sales, $ 99,610 K
  • Annual Income, $ -100,630 K
  • 36-Month Beta 1.41
  • Price/Sales 1.44
  • Price/Cash Flow 10.99
  • Price/Book 1.17

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.91 +5.91%
on 12/27/17
5.65 -7.96%
on 01/10/18
-0.40 (-7.14%)
since 12/22/17
3-Month
4.22 +23.22%
on 10/26/17
5.93 -12.31%
on 12/18/17
+0.40 (+8.33%)
since 10/23/17
52-Week
4.22 +23.22%
on 10/26/17
6.87 -24.31%
on 01/26/17
-1.50 (-22.39%)
since 01/23/17

Most Recent Stories

More News
Glycated Hemoglobin Testing Market Value to Reach US$ 705 million by the End of 2026: Transparency Market Research

Increasing incidences of diabetes have propelled the need for improved diagnostics in the global healthcare devices. Companies manufacturing critical diagnostic devices are focusing on facilitating products...

TRIB : 5.20 (-0.19%)
SIEGY : 76.9900 (+0.63%)
Trinity Biotech Announces Results for Q3, 2017

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September...

TRIB : 5.20 (-0.19%)
Trinity Biotech plc to Announce 2017 Third Quarter Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report 2017 third quarter financial results on...

TRIB : 5.20 (-0.19%)
Enteric Disease Testing Market Driven by Growing Prevalence of Bacterial & Parasitic Diseases, Says TMR

The key players operating in the enteric disease testing market are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept...

TRIB : 5.20 (-0.19%)
DGX : 103.21 (-0.35%)
BMRA : 3.81 (-2.28%)
CPHD : 52.95 (unch)
ALR : 50.99 (unch)
INVESTOR ALERT: Kirby McInerney LLP Commences Investigation on Behalf of Trinity Biotech plc Investors

The law firm of Kirby McInerney LLP announced today an investigation on behalf of investors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ:TRIB) concerning possible violations...

TRIB : 5.20 (-0.19%)
Trinity Biotech Announces Results for Q2, 2017

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June...

TRIB : 5.20 (-0.19%)
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2017 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter...

TRIB : 5.20 (-0.19%)
Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021 - Key vendors are Abbott Laboratories, Alere, Bio-Rad Laboratories & Thermo Fisher Scientifi

Research and Markets has announced the addition of the "Global Anti-nuclear Antibody (ANA) Testing Market 2017-2021" report to their offering. The analysts forecast the global anti-nuclear antibody (ANA)...

TRIB : 5.20 (-0.19%)
ABT : 59.17 (-0.67%)
Harwood Feffer LLP Announces Investigation of Trinity Biotech plc

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against officers and directors of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB).

TRIB : 5.20 (-0.19%)
Trinity Biotech Announces Results for Q1, 2017

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March...

TRIB : 5.20 (-0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Key Turning Points

2nd Resistance Point 5.39
1st Resistance Point 5.30
Last Price 5.20
1st Support Level 5.11
2nd Support Level 5.01

See More

52-Week High 6.87
Fibonacci 61.8% 5.86
Fibonacci 50% 5.55
Fibonacci 38.2% 5.23
Last Price 5.20
52-Week Low 4.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.